Japanese Patent Office Issues Decision to Grant Patent for EndoDrill Technology
The cancer diagnostics company BiBBInstruments AB ("BiBB" or the "Company"), the developer of the world's first market-cleared electric-driven endoscopic core biopsy instrument, announces that the Company has received a Decision to Grant from the Japan Patent Office (JPO). This means that JPO has decided to approve the Company's first patent application in Japan for EndoDrill[®]. A few additional formal steps will follow before a patent is finally issued, after which the granted patent will be valid until October 2039.BIBB has received a Decision to Grant from the JPO for its patent